Carnitine / krebs

Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Fatty acids are catabolized, mostly, in the mitochondria through the .beta.-oxidation pathway, where the carnitine palmitoyltransferase (CPT) system plays a key role in transporting long chain fatty acids (FAs) from the cytoplasm to the mitochondrial matrix. The CPT

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Treatment of cancers

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to the treatment of cancers using aplidine or related compounds which are aplidine analogs. BACKGROUND OF INVENTION Cancer comprises a group of malignant neoplasms that can be divided into two categories, carcinoma, comprising a majority of the cases observed in the

Method of using .beta.-hydroxy-.beta.-methylbutyrate for the treatment of disease conditions

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall

HMB uses thereof

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall

Nutrient compositions and methods for enhanced effectiveness of the immune system

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

This invention relates generally to promoting the healing process of physiological disorders or diseases and, more specifically to nutrient compositions that promote the effectiveness or efficiency of the immune system. Physiological disorders and diseases affect millions of individuals each year.

Nutrient compositions and methods for enhanced effectiveness of the immune system

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

This invention relates generally to promoting the healing process of physiological disorders or diseases and, more specifically to nutrient compositions that promote the effectiveness or efficiency of the immune system. Physiological disorders and diseases affect millions of individuals each year.

Multivitamin-mineral regimens for longevity and wellness

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

CROSS REFERENCE This application claims priority to U.S. patent application Ser. No. 13/043,056 filed Mar. 8, 2011 and U.S. patent application Ser. No. 13/043,216 filed Mar. 8, 2011, the specifications of which are incorporated herein by reference in their entirety. BACKGROUND OF THE INVENTION The

Multivitamin-mineral regimens for longevity and wellness

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION The present invention features novel dietary supplements, which may benefit individuals suffering from various conditions such as nutritional deficiencies, vitamin deficiencies, aging, cancer, dementia/Alzheimer's disease, high blood pressure, high cholesterol, coronary

Multivitamin-mineral regimens for longevity and wellness

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION The present invention features novel dietary supplements, which may benefit individuals suffering from various conditions such as nutritional deficiencies, vitamin deficiencies, aging, cancer, dementia/Alzheimer's disease, high blood pressure, high cholesterol, coronary

Enteral nutritional product

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to an enteral nutritional supplement for persons with cancer who are not currently undergoing radiation therapy and/or chemotherapy. Cancer patients typically undergo intermittent periods of chemotherapy and/or radiation therapy during which their nutritional needs are

Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION This invention relates to a method for increasing the intestinal absorption, cellular concentration, biliary secretion, hepatic storage, and/or liver concentration of a fat soluble vitamin in a post-menopausal woman or a lower animal by orally administering L-carnitine and a

Method of producing therapeutic agent

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND 1. Technical Field of the Invention The present invention relates to a method of producing a therapeutic agent for use in the prevention of cancer that arises from mutations to the BRCA1 and BRCA2 genes, i.e., breast and ovarian, and the treatment of several types of human diseases

carnitine/krebs

Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Treatment of cancers

Method of using .beta.-hydroxy-.beta.-methylbutyrate for the treatment of disease conditions

Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting

HMB uses thereof

Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting

Nutrient compositions and methods for enhanced effectiveness of the immune system

Nutrient compositions and methods for enhanced effectiveness of the immune system

Multivitamin-mineral regimens for longevity and wellness

Multivitamin-mineral regimens for longevity and wellness

Multivitamin-mineral regimens for longevity and wellness

Enteral nutritional product

Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals

Method of producing therapeutic agent

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird